JP2016504351A5 - - Google Patents

Download PDF

Info

Publication number
JP2016504351A5
JP2016504351A5 JP2015550315A JP2015550315A JP2016504351A5 JP 2016504351 A5 JP2016504351 A5 JP 2016504351A5 JP 2015550315 A JP2015550315 A JP 2015550315A JP 2015550315 A JP2015550315 A JP 2015550315A JP 2016504351 A5 JP2016504351 A5 JP 2016504351A5
Authority
JP
Japan
Prior art keywords
diastereomer
enantiomer
isomer
compound according
racemic mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015550315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016504351A (ja
JP6325573B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2013/012204 external-priority patent/WO2014104757A1/ko
Publication of JP2016504351A publication Critical patent/JP2016504351A/ja
Publication of JP2016504351A5 publication Critical patent/JP2016504351A5/ja
Application granted granted Critical
Publication of JP6325573B2 publication Critical patent/JP6325573B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015550315A 2012-12-28 2013-12-26 Btkキナーゼ抑制剤としての2,3−ジヒドロ−イソインドール−1−オン誘導体及びこれを含む薬学的組成物 Active JP6325573B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261746980P 2012-12-28 2012-12-28
US61/746,980 2012-12-28
PCT/KR2013/012204 WO2014104757A1 (ko) 2012-12-28 2013-12-26 Btk 키나아제 억제제로서의 2,3-디하이드로-이소인돌-1-온 유도체 및 이를 함유하는 약학적 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018076877A Division JP6596537B2 (ja) 2012-12-28 2018-04-12 Btkキナーゼ抑制剤としての2,3−ジヒドロ−イソインドール−1−オン誘導体及びこれを含む薬学的組成物

Publications (3)

Publication Number Publication Date
JP2016504351A JP2016504351A (ja) 2016-02-12
JP2016504351A5 true JP2016504351A5 (2) 2017-02-16
JP6325573B2 JP6325573B2 (ja) 2018-05-16

Family

ID=51021712

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015550315A Active JP6325573B2 (ja) 2012-12-28 2013-12-26 Btkキナーゼ抑制剤としての2,3−ジヒドロ−イソインドール−1−オン誘導体及びこれを含む薬学的組成物
JP2018076877A Active JP6596537B2 (ja) 2012-12-28 2018-04-12 Btkキナーゼ抑制剤としての2,3−ジヒドロ−イソインドール−1−オン誘導体及びこれを含む薬学的組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018076877A Active JP6596537B2 (ja) 2012-12-28 2018-04-12 Btkキナーゼ抑制剤としての2,3−ジヒドロ−イソインドール−1−オン誘導体及びこれを含む薬学的組成物

Country Status (15)

Country Link
US (4) US9758508B2 (2)
EP (2) EP3428161B1 (2)
JP (2) JP6325573B2 (2)
KR (1) KR102009163B1 (2)
CN (1) CN104995184B (2)
AU (3) AU2013371146C1 (2)
BR (1) BR112015015477B1 (2)
CA (1) CA2896711C (2)
DK (1) DK2940014T3 (2)
ES (2) ES2929906T3 (2)
MX (2) MX2021011563A (2)
PL (1) PL2940014T3 (2)
PT (1) PT2940014T (2)
RU (2) RU2018138028A (2)
WO (1) WO2014104757A1 (2)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ604708A (en) 2010-05-20 2015-05-29 Array Biopharma Inc Macrocyclic compounds as trk kinase inhibitors
BR112015015477B1 (pt) 2012-12-28 2022-07-12 Crystalgenomics, Inc Derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk
BR112018000808A2 (pt) 2015-07-16 2018-09-04 Array Biopharma Inc compostos de pirazolo[1,5-a]piridina substituída como inibidores de ret cinase
TWI752098B (zh) 2016-10-10 2022-01-11 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
MA46995A (fr) 2016-12-03 2019-10-09 Acerta Pharma Bv Méthodes et compositions pour l'utilisation de lymphocytes t thérapeutiques en association avec des inhibiteurs de kinase
US11168090B2 (en) 2017-01-18 2021-11-09 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
US20180344702A1 (en) * 2017-02-21 2018-12-06 Aptose Biosciences Inc. Methods for treating patients with hematologic malignancies
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
TWI812649B (zh) 2017-10-10 2023-08-21 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
CN111615514B (zh) 2018-01-18 2022-10-11 奥瑞生物药品公司 作为ret激酶抑制剂的取代的吡唑并[4,3-c]吡啶化合物
WO2019143991A1 (en) 2018-01-18 2019-07-25 Array Biopharma Inc. SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS AS RET KINASE INHIBITORS
EP3740491A1 (en) 2018-01-18 2020-11-25 Array Biopharma, Inc. Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
EP3849986B1 (en) 2018-09-10 2022-06-08 Array Biopharma, Inc. Fused heterocyclic compounds as ret kinase inhibitors
CA3133376A1 (en) * 2018-11-30 2020-06-04 Aptose Biosciences Inc. Combination therapy with 2,3-dihydro-isoindole-1-one compounds and methods for treating patients with various mutations
US20220143049A1 (en) 2019-03-21 2022-05-12 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
US20240100172A1 (en) 2020-12-21 2024-03-28 Hangzhou Jijing Pharmaceutical Technology Limited Methods and compounds for targeted autophagy
JP2024502130A (ja) * 2021-01-05 2024-01-17 スミトモ ファーマ オンコロジー, インコーポレイテッド チロシンキナーゼ非受容体1(tnk1)阻害剤の形態及び製剤
EP4301756A4 (en) * 2021-03-05 2025-02-26 Nimbus Saturn, Inc. Hpk1 antagonists and uses thereof
WO2022213062A1 (en) 2021-03-29 2022-10-06 Nimbus Saturn, Inc. Hpk1 antagonists and uses thereof
WO2024245577A1 (en) 2023-06-02 2024-12-05 Netherlands Translational Research Center Holding B.V. Therapeutic combinations of an irreversible btk inhibitor and a reversible btk inhibitor
WO2024245578A1 (en) 2023-06-02 2024-12-05 Netherlands Translational Research Center Holding B.V. Therapeutic combinations of an irreversible btk inhibitor and a macrocyclic reversible btk inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK13682003A3 (sk) * 2001-04-12 2004-07-07 F. Hoffmann-La Roche Ag Dihydrobenzo[b][1,4]diazepin-2-ónové deriváty ako mGluR2 antagonisty II
JP2006526648A (ja) * 2003-06-02 2006-11-24 アボット・ラボラトリーズ キナーゼ阻害剤としてのイソインドリン−1−オン化合物
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
WO2006112479A1 (ja) 2005-04-19 2006-10-26 Kyowa Hakko Kogyo Co., Ltd. 含窒素複素環化合物
US20070161648A1 (en) 2005-10-14 2007-07-12 Hughes Terry V Substituted dihydro-isoindolones useful in treating kinase disorders
JP2009530342A (ja) 2006-03-20 2009-08-27 エフ.ホフマン−ラ ロシュ アーゲー Btkおよびsyk蛋白キナーゼを阻害する方法
JPWO2008047831A1 (ja) * 2006-10-17 2010-02-25 協和発酵キリン株式会社 Jak阻害剤
WO2009053269A1 (en) * 2007-10-23 2009-04-30 F. Hoffmann-La Roche Ag Novel kinase inhibitors
WO2012014017A1 (en) 2010-07-30 2012-02-02 Poly Medicure Limited Catheter introducer
WO2012047017A2 (ko) * 2010-10-05 2012-04-12 크리스탈지노믹스(주) 2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물
BR112015015477B1 (pt) 2012-12-28 2022-07-12 Crystalgenomics, Inc Derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk
US10463658B2 (en) 2013-10-25 2019-11-05 Videra Pharmaceuticals, Llc Method of inhibiting FLT3 kinase

Similar Documents

Publication Publication Date Title
JP2016504351A5 (2)
JP2012081521A5 (2)
JP2012106006A5 (2)
JP2014102408A5 (2)
JP2015125255A5 (2)
JP2013157269A5 (2)
JP2015520667A5 (2)
JP2015078789A5 (2)
JP2016028092A5 (2)
JP2013173781A5 (2)
EA201600091A1 (ru) 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов
JP2016065085A5 (2)
JP2017537928A5 (2)
JP2016182547A5 (2)
JP2015510021A5 (2)
JP2015501646A5 (2)
JP2013500200A5 (2)
JP2017531471A5 (2)
JP2015518492A5 (2)
JP2016520095A5 (2)
JP2020515725A5 (2)
JP2016038993A5 (2)
JP2016516874A5 (2)
JP2013090907A5 (2)
JP2020054657A5 (2)